Biomedus Co., Ltd. (CEO Kim Jong-won) will participate in ‘MEDI EXPO KOREA 6’, which will be held at Daegu EXCO for 30 days from June 7 (Fri) to July 2 (Sun), and display fully automatic molecular Introducing a genetic diagnosis device.
Biomedus, located in Suwon, Gyeonggi-do, is a bio venture company established in May 2017. As a company specializing in smart laboratory and intelligent testing and in vitro diagnostic medical devices, we develop various cutting-edge equipment for bio laboratories, including clinical laboratories. Its main business area is the development and production of next-generation intelligent inspection equipment equipped with IoT or mobile network functions. Based on bio-IT convergence technology, we are developing in vitro diagnostic medical devices and on-site diagnostic testing devices, and based on this, we are also developing the original technology needed to operate a smart biolab or laboratory.
‘LabGenius’, the main exhibit at this exhibition, is a fully automatic point-of-care diagnostic (POCT) device that extracts nucleic acids (RNA or DNA) for the purpose of disease testing, amplifies genes by repeatedly cycling through a specific temperature range, and detects fluorescent substances bound to genes. ) is a device. As an open automated equipment, it is easy to operate by applying reagents from other companies, and based on this, it has the advantage of being relatively easy to cooperate with other reagent manufacturers.
LabGenius is a fully automatic molecular genetic diagnosis device developed with Biomedus’ unique technology and has secured domestic and US patents. Biomedus began research and development of on-site molecular diagnostic device system equipment to expand its molecular diagnostic product pipeline and further solidify its position as an innovative molecular diagnostics company.
Instead of the cumbersome process of confirming the results by amplifying a specific region (sequence) of nucleic acid using polymerase chain reaction (PCR) after the widely used general DNA extraction process, the DNA extraction process and real-time amplification process are performed in one step ( It is designed to be done automatically in one step. Officials explained that a fully automatic nucleic acid extraction and PCR device was developed to enable diagnosis by monitoring the amplification process through fluorescence optics in real time.
Based on these technological capabilities, Biomedus pioneered overseas markets such as the Middle East, Indonesia, and Japan and received certification as an export frontier company in 2021. As of May, the RT-DuxCycler product is in the mass production stage. In response to this, Biomedus said, “RT-DuxCycler is a small but powerful domestic experimental device that can perform real-time DNA polymerase chain reaction (qPCR) in 5 wells simultaneously,” and added, “The device is light and portable and can be used in laboratories with limited space. It is a device that supports the environment. “We plan to continue to develop and release various in vitro diagnostic medical devices and diagnostic kits.”
Meanwhile, the main exhibition items at Medi Expo Korea are as follows. △ Imaging medical devices △ Measurement medical devices △ Rehabilitation medical devices △ Healthcare medical devices △ Surgery-related devices △ Medical information systems △ Smart health devices △ Pharmaceutical-related devices △ Medical device parts and materials △ Hospital equipment △ Oriental medicine devices △ Dental-related devices △ Exercise-related equipment △Skin care beauty △Senior-friendly products △Health food and supplies △Medical tourism △Specialized hospitals